Yokohama, Japan

Makoto Odate


Average Co-Inventor Count = 5.4

ph-index = 5

Forward Citations = 100(Granted Patents)


Location History:

  • Kanagawa, JP (1989 - 1991)
  • Yokohama, JP (1981 - 1995)

Company Filing History:


Years Active: 1981-1995

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Makoto Odate

Introduction

Makoto Odate is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of chemistry, particularly in the development of heterocyclic compounds that serve as anticancer drug potentiaters. With a total of 8 patents to his name, Odate's work has the potential to impact cancer treatment significantly.

Latest Patents

Odate's latest patents focus on quinoline derivatives and heterocyclic compounds. These compounds are designed to enhance the incorporation of anticancer drugs into cancer cells. The synthesis of these compounds involves reacting an epoxy compound, derived from a heterocyclic compound and an epihalogenohydrin, with an amine derivative. This innovative approach aims to improve the efficacy of existing anticancer therapies.

Career Highlights

Throughout his career, Makoto Odate has worked with notable companies such as Mitsui Toatsu Chemicals, Incorporated and Mitsui Toatsu Kagaku Kabushiki Kaisha. His experience in these organizations has allowed him to refine his expertise in chemical synthesis and drug development.

Collaborations

Odate has collaborated with esteemed colleagues, including Nobuyuki Fukazawa and Tsuneji Suzuki. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Makoto Odate's contributions to the field of chemistry, particularly in the development of anticancer drug potentiaters, highlight his innovative spirit and dedication to improving cancer treatment. His work continues to inspire future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…